Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 23, 2023
0Patent Application Number
168708030
Date Filed
May 8, 2020
0Patent Citations
...
Patent Primary Examiner
CPC Code
There are provided, inter alia, compositions and methods for treatment of cancer. The methods include administering to a subject in need a therapeutically effective amount of a Bruton's tyrosine kinase (BTK) antagonist and a ROR-1 antagonist. Further provided are pharmaceutical compositions including a BTK antagonist, ROR-1 antagonist and a pharmaceutically acceptable excipient. In embodiments, the BTK antagonist is ibrutinib and the ROR-1 antagonist is cirmtuzumab.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
